Active Surveillance Exercise Clinical Trial

NACompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

June 21, 2016

Primary Completion Date

April 30, 2023

Study Completion Date

December 31, 2024

Conditions
Localized Prostate CancerActive Surveillance for Prostate Cancer
Interventions
BEHAVIORAL

Exercise

This open-label, two-arm randomized controlled trial (RCT) will investigate the effects of 16 weeks of structured aerobic training, relative to usual care (print material with physical activity guidance) in 76 men with histologically confirmed low-risk prostate adenocarcinoma on active surveillance. The only investigational therapeutic agent being tested in this trial is a behavioral intervention in the form of aerobic training.

OTHER

Cardiopulmonary Exercise Test (CPET)

Exercise capacity test to assess peak oxygen consumption (VO2peak)

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Francisco

OTHER

NCT02435472 - Active Surveillance Exercise Clinical Trial | Biotech Hunter | Biotech Hunter